Average Reviews:
(More customer reviews)Friedman's 'Building Biotechnology' provides a good holistic introduction to the business of biotech. It is concisely written in layman's terms, with short & sweet case studies through out the book. What I find weak about the book is its limited coverage on the important topic of biotech valuation (readers who are interested in that topic can check out Peter Boer's 'Technology Valuation Solutions', or Richard Razgaitis's 'Valuation and Pricing of Technology-based Intellectual Property').
Click Here to see more reviews about: Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies - Business Development, Entrepreneurship, Careers, Investing, Science, Patents and Regulations
Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that define the scope of biotechnology. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in more than fifteen advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Schulich; the Johns Hopkins biotechnology MS/MBA program; and extension programs at Berkeley and UC San Francisco. This second edition significantly expands upon the foundation laid by the first, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables.
0 comments:
Post a Comment